« Back to Record
Citation APA

Henzi, B. C., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lobato, M. L., Osorio, A. N., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., & Fischer, D. (2025). Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B). Neuromuscular disorders, 47, 105275. doi:10.1016/j.nmd.2025.105275


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/390929

Henzi, B. C., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lobato, M. L., Osorio, A. N., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., & Fischer, D. (2025). Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B). Neuromuscular disorders, 47, 105275. doi:10.1016/j.nmd.2025.105275